RAD

When It Comes to Drug Stores, Second-Place CVS Gets the Gold

CVS might not be the market leader for drug stores, but it's certainly a better buy than Walgreen. And don't even think about Rite Aid. More 

CPI, KO Take out the Fizzle: Tuesday’s IP Market Recap

Coca-Cola and Goldman Sachs were among blue-chips sinking after earnings; meanwhile, Tesla slumped after a bearish analyst outlook. More 

Go Ahead, Be Dumb. Buy Rite Aid

It's really quite simple: Drugstores are dead. Don't buy them. Ever. More 

Pharmacy Wars: Walgreens vs. CVS

The two largest U.S. pharmacy chains have both come roaring back, but which one -- CVS or Walgreens -- is the better bet for investors? Let's break it down. More 

Bears Bury Wall Street: Thursday’s IP Market Recap

Wednesday's afternoon bleeding flowed right into Thursday, with the Dow Jones shedding 353.87 points for its worst performance of the year. More 

Lululemon Drops: 6 Stocks in 60 Seconds

This week: Lululemon drops important news about its corner office. Plus, find out which drugstore chain has more than doubled so far in 2013. More 

Earnings Loom for Rocketing Rite Aid

Earnings announcements can be a volatile devil quick to steal shareholders’ profits, so with Rite Aid's report on the horizon, RAD shareholders should get protective. More